2002
DOI: 10.1161/01.cir.0000035275.64667.a3
|View full text |Cite
|
Sign up to set email alerts
|

Vaccination Against Atherosclerosis

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

3
26
0

Year Published

2003
2003
2023
2023

Publication Types

Select...
6
4

Relationship

0
10

Authors

Journals

citations
Cited by 53 publications
(29 citation statements)
references
References 21 publications
3
26
0
Order By: Relevance
“…3 This has stimulated the development of novel therapies for prevention and treatment of CVD targeting the immune system. 38,39 However, an important limitation in this development has been the poor understanding of the role of the immune system in the development of atherosclerosis and acute cardiovascular events in humans. The present report is the first prospective study of associations between Th1 and Th2 cells with the risk for acute myocardial infarction and stroke.…”
Section: Discussionmentioning
confidence: 99%
“…3 This has stimulated the development of novel therapies for prevention and treatment of CVD targeting the immune system. 38,39 However, an important limitation in this development has been the poor understanding of the role of the immune system in the development of atherosclerosis and acute cardiovascular events in humans. The present report is the first prospective study of associations between Th1 and Th2 cells with the risk for acute myocardial infarction and stroke.…”
Section: Discussionmentioning
confidence: 99%
“…Although there is a general consensus supporting the involvement of immunological mechanisms in the pathogenesis of atherosclerosis (2,21,22), there are real differences of opinion about the significance of humoral immunity mechanisms, particularly of the autoimmune response elicited by modified lipoproteins (23)(24)(25)(26). Most of the controversy centers on whether such antibodies have proinflammatory or protective properties and it is a result of data obtained in animal models (27)(28)(29)(30).…”
Section: Discussionmentioning
confidence: 99%
“…The uncertainty results from two sets of observations: animal experiments that have been interpreted as suggesting a protective role for oxLDL antibodies (13) and conflicting data obtained in clinical and epidemiological studies that tried to correlate levels of oxLDL antibodies in serum with different end points of arteriosclerosis. These discrepancies are likely to result from multiple factors, including individual variations in the immune response, affecting concentration, isotype, and avidity of the autoantibodies, and inaccuracy of the assays, highly influenced by differences in antibody avidity and by the presence of soluble IC.…”
mentioning
confidence: 99%